The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

The clear guidelines for nasal spray formulations will brings in uniformity in composition, strengthening efficacy, stated experts. In ASU formulations, there are three different types of nasya ...

The global landscape of neurological health is undergoing a transformative moment with a pioneering nasal spray that could potentially ... this innovation could inspire a new generation of ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment ...

Jan. 27, 2025 – After years of limited options, people with hard-to-treat depression finally have a new standalone treatment. The FDA’s latest approval of the nasal spray Spravato (esketamine ...

9NEWS Medical Expert Dr. Payal Kohli weighs in on a new nasal spray being used to treat depression. What this volunteer has found in charred wreckage of LA fires Can you name the oldest city in ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

The US Food and Drug Administration (FDA) has approved the use of esketamine nasal spray as a standalone treatment for adults with major depressive disorder (MDD) who have not responded adequately ...

Objective: To investigate the effect of Mometasone furoate (Elocon Cream) Nasal Spray (MFNS) treatment on hearing secretory Otitis Media (SOM) in younger children. Methods: Seventy-six children with ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.